Pancreatic cancer.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Current Problems in Cancer

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1891/9781617052828.0021PMID 12399802
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Epidemiology and prevention of pancreatic cancer.

  2004cited by this paper
• Pancreaticoduodenectomy: Role of interventional radiologists in managing patients and complications

  2003cited by this paper
• Multidetector CT and three-dimensional imaging of the pancreas: State of the art

  2002cited by this paper
• Overexpression of S100A4 in pancreatic ductal adenocarcinomas is associated with poor differentiation and DNA hypomethylation.

  2002cited by this paper
• Evidence for a major gene influencing risk of pancreatic cancer

  2002cited by this paper
• Gemcitabine alone or with cisplatin for the treatment of patients with locally advanced and/or metastatic pancreatic carcinoma

  2002cited by this paper
• Discovery of novel tumor markers of pancreatic cancer using global gene expression technology.

  2002cited by this paper
• Relationships and differentially expressed genes among pancreatic cancers examined by large-scale serial analysis of gene expression.

  2002cited by this paper
• Hospital volume and surgical mortality in the United States.

  2002cited by this paper
• Solid-pseudopapillary tumors of the pancreas are genetically distinct from pancreatic ductal adenocarcinomas and almost always harbor beta-catenin mutations.

  2002cited by this paper
• Serum protein fingerprinting coupled with a pattern-matching algorithm distinguishes prostate cancer from benign prostate hyperplasia and healthy men.

  2002cited by this paper
• Use of proteomic patterns in serum to identify ovarian cancer.

  2002cited by this paper
• Phenotypic variation in eight extended CDKN2A germline mutation familial atypical multiple mole melanoma–pancreatic carcinoma–prone families

  2002cited by this paper
• Preoperative Chemoradiation in the Management of Adenocarcinoma of the Body of the Pancreas

  2002cited by this paper
• Imaging of pancreatic cancer using fluorine-18 fluorodeoxyglucose positron emission tomography

  2002cited by this paper
• Epidemiologic and etiologic factors of pancreatic cancer.

  2002cited by this paper
• Almost All Infiltrating Colloid Carcinomas of the Pancreas and Periampullary Region Arise From In Situ Papillary Neoplasms: A Study of 39 Cases

  2002cited by this paper
• The epidermal growth factor receptor: a new target for anticancer therapy.

  2002cited by this paper
• Pancreaticoduodenectomy With or Without Distal Gastrectomy and Extended Retroperitoneal Lymphadenectomy for Periampullary Adenocarcinoma, Part 2: Randomized Controlled Trial Evaluating Survival, Morbidity, and Mortality

  2002cited by this paper
• A new susceptibility locus for autosomal dominant pancreatic cancer maps to chromosome 4q32-34.

  2002cited by this paper
• The fundamental role of epigenetic events in cancer

  2002cited by this paper
• Gemcitabine exerts a selective effect on the humoral immune response: implications for combination chemo-immunotherapy.

  2002cited by this paper
• Diagnostic laparoscopy for periampullary and pancreatic cancer: What is the true benefit?

  2002cited by this paper
• Abstracts reprinted from Journal of Clinical Oncology

  2002cited by this paper
• Exploring the host desmoplastic response to pancreatic carcinoma: gene expression of stromal and neoplastic cells at the site of primary invasion.

  2002cited by this paper
• Identification of hepatocarcinoma-intestine-pancreas/pancreatitis-associated protein I as a biomarker for pancreatic ductal adenocarcinoma by protein biochip technology.

  2002cited by this paper
• Risk of pancreatic cancer among individuals with a family history of cancer of the pancreas

  2002cited by this paper
• Endoscopic ultrasonography

  2002cited by this paper
• Magnetic resonance imaging of the pancreas in 2001

  2002cited by this paper
• Genetic and immunohistochemical analysis of pancreatic acinar cell carcinoma: frequent allelic loss on chromosome 11p and alterations in the APC/beta-catenin pathway.

  2002cited by this paper
• Concurrent chemoradiotherapy with gemcitabine and cisplatin for pancreatic cancer: from the laboratory to the clinic.

  2002cited by this paper
• Cancer Statistics, 2001

  2001cited by this paper
• A phase II trial of marimastat in advanced pancreatic cancer

  2001cited by this paper
• Developmental aspects of early pancreatic cancer.

  2001cited by this paper
• Lineage Commitment and Cellular Differentiation in Exocrine Pancreas

  2001cited by this paper
• Discovery of new markers of cancer through serial analysis of gene expression: prostate stem cell antigen is overexpressed in pancreatic adenocarcinoma.

  2001cited by this paper
• Novel allogeneic granulocyte-macrophage colony-stimulating factor-secreting tumor vaccine for pancreatic cancer: a phase I trial of safety and immune activation.

  2001cited by this paper
• Clinical usefulness of K-ras gene mutation detection and cytology in pancreatic juice in the diagnosis and screening of pancreatic cancer

  2001cited by this paper
• Invasion-specific genes in malignancy: serial analysis of gene expression comparisons of primary and passaged cancers.

  2001cited by this paper
• Combined-modality therapy in pancreatic cancer: current status and future directions.

  2001cited by this paper
• Intradermal ras peptide vaccination with granulocyte‐macrophage colony‐stimulating factor as adjuvant: Clinical and immunological responses in patients with pancreatic adenocarcinoma

  2001cited by this paper
• Phase I trial of gemcitabine combined with radiation for the treatment of locally advanced pancreatic adenocarcinoma.

  2001cited by this paper
• Development of matrix metalloproteinase inhibitors in cancer therapy.

  2001cited by this paper
• A gene hypermethylation profile of human cancer.

  2001cited by this paper
• A murine tumor progression model for pancreatic cancer recapitulating the genetic alterations of the human disease.

  2001cited by this paper
• Physical activity, obesity, height, and the risk of pancreatic cancer.

  2001cited by this paper
• Intraductal Papillary Mucinous Neoplasms of the Pancreas: An Increasingly Recognized Clinicopathologic Entity

  2001cited by this paper
• Is the therapeutic index better with gemcitabine-based chemoradiation than with 5-fluorouracil-based chemoradiation in locally advanced pancreatic cancer?

  2001cited by this paper
• ACVR1B (ALK4, activin receptor type 1B) gene mutations in pancreatic carcinoma

  2001cited by this paper
• Endoscopic UltrasonographyGuided Fine-Needle Aspiration Biopsy of Suspected Pancreatic Cancer

  2001cited by this paper
• Distinctive molecular genetic alterations in sporadic and familial adenomatous polyposis-associated pancreatoblastomas : frequent alterations in the APC/beta-catenin pathway and chromosome 11p.

  2001cited by this paper
• Identification and characterization of differentially methylated CpG islands in pancreatic carcinoma.

  2001cited by this paper
• Phase I trial of radiation dose escalation with concurrent weekly full-dose gemcitabine in patients with advanced pancreatic cancer.

  2001cited by this paper
• Phase II study of gemcitabine and cisplatin in the treatment of patients with advanced pancreatic carcinoma

  2001cited by this paper
• Pancreatic Intraepithelial Neoplasia: A New Nomenclature and Classification System for Pancreatic Duct Lesions

  2001cited by this paper
• Increased risk of incident pancreatic cancer among first-degree relatives of patients with familial pancreatic cancer.

  2001cited by this paper
• Mesothelin is overexpressed in the vast majority of ductal adenocarcinomas of the pancreas: identification of a new pancreatic cancer marker by serial analysis of gene expression (SAGE).

  2001cited by this paper
• Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomised controlled trial.

  2001cited by this paper
• Blocking oncogenic Ras signaling for cancer therapy.

  2001cited by this paper
• Detection of breast cancer cells in ductal lavage fluid by methylation-specific PCR.

  2001cited by this paper
• Marimastat as first-line therapy for patients with unresectable pancreatic cancer: a randomized trial.

  2001cited by this paper
• EUS, PET, and CT scanning for evaluation of pancreatic adenocarcinoma.

  2000cited by this paper
• Control of endodermal endocrine development by Hes-1

  2000cited by this paper
• Predictors of pancreatic cancer mortality among a large cohort of United States adults

  2000cited by this paper
• Loss of expression of Dpc4 in pancreatic intraepithelial neoplasia: evidence that DPC4 inactivation occurs late in neoplastic progression.

  2000cited by this paper
• Expression and role of laminin-1 in mouse pancreatic organogenesis.

  2000cited by this paper
• Genetic, immunohistochemical, and clinical features of medullary carcinoma of the pancreas: A newly described and characterized entity.

  2000cited by this paper
• Dpc-4 protein is expressed in virtually all human intraductal papillary mucinous neoplasms of the pancreas: comparison with conventional ductal adenocarcinomas.

  2000cited by this paper
• Abnormal glucose metabolism and pancreatic cancer mortality.

  2000cited by this paper
• Immunohistochemical labeling for dpc4 mirrors genetic status in pancreatic adenocarcinomas : a new marker of DPC4 inactivation.

  2000cited by this paper
• Interferon-based adjuvant chemoradiation therapy improves survival after pancreaticoduodenectomy for pancreatic adenocarcinoma.

  2000cited by this paper
• Eastern Cooperative Oncology Group Phase I trial of protracted venous infusion fluorouracil plus weekly gemcitabine with concurrent radiation therapy in patients with locally advanced pancreas cancer: a regimen with unexpected early toxicity.

  2000cited by this paper
• Resected adenocarcinoma of the pancreas— 616 patients: Results, outcomes, and prognostic indicators

  2000cited by this paper
• Adjuvant radiotherapy and concomitant 5-fluorouracil by protracted venous infusion for resected pancreatic cancer.

  2000cited by this paper
• BRCA2 is inactivated late in the development of pancreatic intraepithelial neoplasia: evidence and implications.

  2000cited by this paper
• High frequency of multiple melanomas and breast and pancreas carcinomas in CDKN2A mutation-positive melanoma families.

  2000cited by this paper
• Multidetector CT Angiography in the Evaluation of Pancreatic Carcinoma: Preliminary Observations

  2000cited by this paper
• Hypermethylation of multiple genes in pancreatic adenocarcinoma.

  2000cited by this paper
• 18Fluorodeoxyglucose-positron emission tomography in the management of patients with suspected pancreatic cancer.

  1999cited by this paper
• The impact of smoking on future pancreatic cancer: a computer simulation.

  1999cited by this paper
• Germline and somatic mutations of the STK11/LKB1 Peutz-Jeghers gene in pancreatic and biliary cancers.

  1999cited by this paper
• Identification and classification of p53-regulated genes.

  1999cited by this paper
• Mucinous cystic neoplasm (mucinous cystadenocarcinoma of low-grade malignant potential) of the pancreas: a clinicopathologic study of 130 cases.

  1999cited by this paper
• Intensified adjuvant therapy for pancreatic and periampullary adenocarcinoma: survival results and observations regarding patterns of failure, radiotherapy dose and CA19-9 levels.

  1999cited by this paper
• Cancer risks in BRCA2 mutation carriers.

  1999cited by this paper
• Pathologic examination accurately predicts prognosis in mucinous cystic neoplasms of the pancreas.

  1999cited by this paper
• Diabetes mellitus, other medical conditions and familial history of cancer as risk factors for pancreatic cancer

  1999cited by this paper
• Radiosensitization by gemcitabine.

  1999cited by this paper
• Expansion of Pdx1-expressing pancreatic epithelium and islet neogenesis in transgenic mice overexpressing transforming growth factor alpha.

  1999cited by this paper
• Surgical palliation of unresectable periampullary adenocarcinoma in the 1990s.

  1999cited by this paper
• Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: phase III trial of the EORTC gastrointestinal tract cancer cooperative group.

  1999cited by this paper
• Pancreaticoduodenectomy with or without extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma: comparison of morbidity and mortality and short-term outcome.

  1999cited by this paper
• Optimal interpretation of FDG PET in the diagnosis, staging and management of pancreatic carcinoma.

  1999cited by this paper
• Is prophylactic gastrojejunostomy indicated for unresectable periampullary cancer? A prospective randomized trial.

  1999cited by this paper
• Phase I trial of twice-weekly gemcitabine and concurrent radiation in patients with advanced pancreatic cancer.

  1999cited by this paper
• The Whipple procedure in the 1990s.

  1999cited by this paper
• Notch signalling controls pancreatic cell differentiation

  1999cited by this paper
• Early Diagnosis and Treatment of Pancreatic Dysplasia in Patients with a Family History of Pancreatic Cancer

  1999cited by this paper
• Pancreas: how to get there from the gut?

  1999cited by this paper
• Alterations in pancreatic, biliary, and breast carcinomas support MKK4 as a genetically targeted tumor suppressor gene.

  1998cited by this paper

• The utility of miRNA 221 & miRNA 199-a in the diagnosis of pancreatic adenocarcinoma.

  2025cites this paper
• Psychological capital and death anxiety in pancreatic cancer patients: a latent profile analysis

  2025cites this paper
• Emerging Multifunctional Carbon‐Nanomaterial‐Based Biosensors for Cancer Diagnosis

  2024cites this paper
• Increased Vitamin C Intake Is Associated With Decreased Pancreatic Cancer Risk

  2024cites this paper
• Evaluating the relationship between patient activation and health-related quality of life (HRQOL) in patients with pancreatic cancer (PwPC)

  2023cites this paper
• Nanoparticles in the diagnosis and treatment of cancer metastases: Current and future perspectives.

  2023cites this paper
• Involved-Field Radiation Therapy for Patients With Unresectable Pancreatic Adenocarcinomas: Failure Pattern Analysis

  2023cites this paper
• circACTR2 attenuates gemcitabine chemoresiatance in pancreatic cancer through PTEN mediated PI3K/AKT signaling pathway

  2023cites this paper
• Postchemoradiotherapy Neutrophil-to-Lymphocyte Ratio Predicts Distant Metastasis and Survival Results in Locally Advanced Pancreatic Cancers

  2022cites this paper
• Benefitial role of electrochemotherapy in locally advanced pancreatic cancer – radiological perspective

  2022cites this paper
• Investigation of Relation of Radiation Therapy Quality With Toxicity and Survival in LAP07 Phase 3 Trial for Locally Advanced Pancreatic Carcinoma.

  2021cites this paper
• Mild hyperthermia promotes immune checkpoint blockade-based immunotherapy against metastatic pancreatic cancer using size-adjustable nanoparticles.

  2021cites this paper
• A review of lifestyle and environment risk factors for pancreatic cancer.

  2021cites this paper
• Current controversies and advances in the management of pancreatic adenocarcinoma

  2021cites this paper
• Nanotechnology and pancreatic cancer management: State of the art and further perspectives

  2021cites this paper
• MicroRNA-361 reduces the viability and migratory ability of pancreatic cancer cells via mediation of the MAPK/JNK pathway

  2021cites this paper
• Low Systemic Inflammation Response Index Predicts Good Prognosis in Locally Advanced Pancreatic Carcinoma Patients Treated with Concurrent Chemoradiotherapy

  2020cites this paper
• Kras mutation rate precisely orchestrates ductal derived pancreatic intraepithelial neoplasia and pancreatic cancer

  2020cites this paper
• Investigation of human pancreatic cancer tissues by Fourier Transform Infrared Hyperspectral Imaging

  2019cites this paper
• Promoter methylation of ADAMTS1 and BNC1 as potential biomarkers for early detection of pancreatic cancer in blood

  2019cites this paper
• POLE Score: a comprehensive profiling of programmed death 1 ligand 1 expression in pancreatic ductal adenocarcinoma

  2019cites this paper
• Early variation of 18-fluorine-labelled fluorodeoxyglucose PET-derived parameters after chemoradiotherapy as predictors of survival in locally advanced pancreatic carcinoma patients.

  2019cites this paper
• A New Strategy to Control and Eradicate “Undruggable” Oncogenic K-RAS-Driven Pancreatic Cancer: Molecular Insights and Core Principles Learned from Developmental and Evolutionary Biology

  2018cites this paper
• Robotic distal pancreatectomy with selective closure of pancreatic duct: surgical outcomes

  2018cites this paper
• Multifunctional thiosemicarbazones and deconstructed analogues as a strategy to study the involvement of metal chelation, Sigma-2 (σ2) receptor and P-gp protein in the cytotoxic action: In vitro and in vivo activity in pancreatic tumors.

  2018cites this paper
• Hormonal factors and pancreatic cancer risk in women: The Malmö Diet and Cancer Study

  2018cites this paper
• Transcriptome analysis of pancreatic cancer cell response to treatment with grape seed proanthocyanidins

  2018cites this paper
• Phase II study of induction chemotherapy followed by chemoradiotherapy in patients with borderline resectable and unresectable locally advanced pancreatic cancer

  2017cites this paper
• Irreversible electroporation as treatment of locally advanced and as margin accentuation in borderline resectable pancreatic adenocarcinoma

  2017cites this paper
• Localized pancreatic cancer with positive peritoneal cytology as a sole manifestation of metastatic disease: a single-institution experience.

  2017cites this paper
• Correlation of 18F-Fluorodeoxyglucose Positron Emission Tomography Parameters with Patterns of Disease Progression in Locally Advanced Pancreatic Cancer after Definitive Chemoradiotherapy

  2017cites this paper
• Diagnostic performance enhancement of pancreatic cancer using proteomic multimarker panel

  2017cites this paper
• Prognostic value of 18F-FDG-PET/CT parameters in patients with pancreatic carcinoma

  2017cites this paper
• Reirradiation with stereotactic body radiation therapy after prior conventional fractionation radiation for locally recurrent pancreatic adenocarcinoma

  2017cites this paper
• Irreversible electroporation for locally advanced pancreatic cancer through a minimally invasive surgery supported by laparoscopic ultrasound

  2017cites this paper
• Superior mesenteric artery margin in pancreaticoduodenectomy for pancreatic adenocarcinoma

  2016cites this paper
• MicroRNA-891b is an independent prognostic factor of pancreatic cancer by targeting Cbl-b to suppress the growth of pancreatic cancer cells

  2016cites this paper
• What are the current and potential future roles for endoscopic ultrasound in the treatment of pancreatic cancer?

  2016cites this paper
• dCK Expression and Gene Polymorphism With Gemcitabine Chemosensitivity in Patients With Pancreatic Ductal Adenocarcinoma

  2016cites this paper
• Irreversible electroporation: state of the art

  2016cites this paper
• Pancreatic cancer risk in relation to sex, lifestyle factors, and pre-diagnostic anthropometry in the Malmö Diet and Cancer Study

  2016cites this paper
• Endoscopic palliation of malignant biliary strictures.

  2016cites this paper
• ADIOTHERAPY IN LOCALLY ADVANCED PANCREATIC CANCER

  2016cites this paper
• Longitudinal Bioluminescence Imaging of Primary Versus Abdominal Metastatic Tumor Growth in Orthotopic Pancreatic Tumor Models in NSG Mice

  2015cites this paper
• Selective impact of CDK4/6 suppression on patient-derived models of pancreatic cancer

  2015cites this paper
• A Meta-analysis of Randomized Clinical Trials of Chemoradiation Therapy in Locally Advanced Pancreatic Cancer

  2015cites this paper
• Mining the Human Proteome: Biomarker Discovery for Human Cancer and Metastases

  2015cites this paper
• Place de la radiothérapie (et chimioradiothérapie) dans les cancers localement avancés ou borderline. Quelles perspectives ?

  2015cites this paper
• Expression pattern and prognostic significance of claudin 1, 4 and 7 in pancreatic cancer.

  2015cites this paper
• Safety and Feasibility of Irreversible Electroporation (IRE) in Patients with Locally Advanced Pancreatic Cancer: Results of a Prospective Study

  2015cites this paper
• Full-Dose Gemcitabine Is a More Effective Chemotherapeutic Agent Than 5-Fluorouracil for Concurrent Chemoradiotherapy as First-Line Treatment in Locally Advanced Pancreatic Cancer

  2015cites this paper
• Snail transcript levels in diagnosis of pancreatic carcinoma with fine-needle aspirate

  2015cites this paper
• Curcumin induces apoptosis in pancreatic cancer cells through the induction of forkhead box O1 and inhibition of the PI3K/Akt pathway.

  2015cites this paper
• A phase I/II study of fixed-dose-rate gemcitabine and S-1 with concurrent radiotherapy for locally advanced pancreatic cancer

  2015cites this paper
• Colonic and anal metastases from pancreato-biliary malignancies.

  2014cites this paper
• Urinary TIMP-1 and MMP-2 levels detect the presence of pancreatic malignancies

  2014cites this paper
• miR‐545 inhibited pancreatic ductal adenocarcinoma growth by targeting RIG‐I

  2014cites this paper
• Radiation dose responses for chemoradiation therapy of pancreatic cancer: an analysis of compiled clinical data using biophysical models.

  2014cites this paper
• Glaucarubinone and gemcitabine synergistically reduce pancreatic cancer growth via down-regulation of P21-activated kinases.

  2014cites this paper
• Imbalanced expression of Tif1γ inhibits pancreatic ductal epithelial cell growth.

  2014cites this paper
• Role of solute carrier transporters in pancreatic cancer: a review.

  2014cites this paper
• FOXM1 and its oncogenic signaling in pancreatic cancer pathogenesis.

  2014cites this paper
• Distal cholangiocarcinoma.

  2014cites this paper
• Presence of primary cilia in cancer cells correlates with prognosis of pancreatic ductal adenocarcinoma.

  2014cites this paper
• Pancreatic resection in elderly patients: should it be denied?

  2014cites this paper
• Locally advanced pancreatic cancer: the role of definitive chemoradiotherapy.

  2014cites this paper
• Role of endoscopic ultrasound in the diagnosis of pancreatic cancer.

  2014cites this paper
• Challenges in using 18 F-fluorodeoxyglucose-PET-CT to define a biological radiotherapy boost volume in locally advanced pancreatic cancer

  2014cites this paper
• Elongation factor-2 kinase regulates TG2/β1 integrin/Src/uPAR pathway and epithelial–mesenchymal transition mediating pancreatic cancer cells invasion

  2014cites this paper
• Integrated Genomic, Transcriptomic, and RNA-Interference Analysis of Genes in Somatic Copy Number Gains in Pancreatic Ductal Adenocarcinoma

  2013cites this paper
• Evaluation of Trace Elements in Pancreatic Cancer Patients in Iran

  2013cites this paper
• In vivo optical spectroscopy for improved detection of pancreatic adenocarcinoma: a feasibility study.

  2013cites this paper
• 18-Fluorodeoxyglucose positron emission tomography does not aid in diagnosis of pancreatic ductal adenocarcinoma.

  2013cites this paper
• Targeted Degradation of KRAS by an Engineered Ubiquitin Ligase Suppresses Pancreatic Cancer Cell Growth In Vitro and In Vivo

  2013cites this paper
• Caffeic Acid Phenethyl Ester Inhibits Epithelial-Mesenchymal Transition of Human Pancreatic Cancer Cells

  2013cites this paper
• Phase 2 study of erlotinib combined with adjuvant chemoradiation and chemotherapy in patients with resectable pancreatic cancer.

  2013cites this paper
• Sweating the small stuff: microRNAs and genetic changes define pancreatic cancer.

  2013cites this paper
• Hedgehog signaling pathway regulates human pancreatic cancer cell proliferation and metastasis.

  2013cites this paper
• RABL6A Promotes Oxaliplatin Resistance in Tumor Cells and Is a New Marker of Survival for Resected Pancreatic Ductal Adenocarcinoma Patients.

  2013cites this paper
• Combination chemotherapy of serine protease inhibitor nafamostat mesilate with oxaliplatin targeting NF-κB activation for pancreatic cancer.

  2013cites this paper
• The molecular mechanism of action of aspirin, curcumin and sulforaphane combinations in the chemoprevention of pancreatic cancer

  2013cites this paper
• Grape seed proanthocyanidins inhibit migration potential of pancreatic cancer cells by promoting mesenchymal-to-epithelial transition and targeting NF-κB.

  2013cites this paper
• Diagnosis of pancreatic neoplasia

  2012cites this paper
• Pancreatic Adenocarcinoma, version 2.2012: featured updates to the NCCN Guidelines.

  2012cites this paper
• Pancreatic cancer: medical management (novel chemotherapeutics).

  2012cites this paper
• Pancreatic Cancer in HIV-Positive Patients: A Clinical Case-Control Study

  2012cites this paper
• The novel hypoxic cytotoxin, TX-2098 has antitumor effect in pancreatic cancer; possible mechanism through inhibiting VEGF and hypoxia inducible factor-1α targeted gene expression.

  2012cites this paper
• The HMGA1-COX-2 axis: a key molecular pathway and potential target in pancreatic adenocarcinoma.

  2012cites this paper
• Claudin-4 Expression Predicts Survival in Pancreatic Ductal Adenocarcinoma

  2012cites this paper
• Radiotherapy technical considerations in the management of locally advanced pancreatic cancer: American-French consensus recommendations.

  2012cites this paper
• The molecular and cellular heterogeneity of pancreatic ductal adenocarcinoma

  2012cites this paper
• Inhibition of sonic hedgehog pathway and pluripotency maintaining factors regulate human pancreatic cancer stem cell characteristics

  2012cites this paper
• Grape Proanthocyanidin Inhibit Pancreatic Cancer Cell Growth In Vitro and In Vivo through Induction of Apoptosis and by Targeting the PI3K/Akt Pathway

  2012cites this paper
• Evaluation of serum diagnosis of pancreatic cancer by using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry.

  2012cites this paper
• Biomarker-driven trial in metastatic pancreas cancer: feasibility in a multicenter study of saracatinib, an oral Src inhibitor, in previously treated pancreatic cancer

  2012cites this paper
• The basic helix-loop-helix transcription factor DEC2 inhibits TGF-β-induced tumor progression in human pancreatic cancer BxPC-3 cells.

  2012cites this paper
• Differential expression of RBM5 and KRAS in pancreatic ductal adenocarcinoma and their association with clinicopathological features

  2012cites this paper
• Global microRNA expression profiling of microdissected tissues identifies miR‐135b as a novel biomarker for pancreatic ductal adenocarcinoma

  2012cites this paper
• Role of Guided - Fine Needle Biopsy of the Pancreatic Lesion

  2012cites this paper
• The ARF Tumor Suppressor Inhibits Tumor Cell Colonization Independent of p53 in a Novel Mouse Model of Pancreatic Ductal Adenocarcinoma Metastasis

  2011cites this paper